Akebia Therapeutics, Inc. (AKBA) Insider Trading

Name: Akebia Therapeutics, Inc. (AKBA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 10, 2026): Butler John P. (CEO and President): Exercise/Conversion of 350,000 shares, $220.5K.

Get alerted when insiders trade AKBA

Email address

Loading company data...

Beta

Loading company details...

Beta